Guided Therapeutics (GTHP) Change in Accured Expenses (2011 - 2025)

Guided Therapeutics (GTHP) has 15 years of Change in Accured Expenses data on file, last reported at $832000.0 in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses rose 433.33% year-over-year to $832000.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 150.09% YoY), and the FY2025 full-year result was $1.4 million, up 150.09% from the prior year.
• Change in Accured Expenses rose to $832000.0 in Q4 2025, from $204000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $832000.0 in Q4 2025 to a low of -$450000.0 in Q3 2021.
• A 5-year average of $110450.0 and a median of $75000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses plunged 454.33% in 2021 and soared 2009.52% in 2024, its largest moves.
• Tracing GTHP's Change in Accured Expenses over 5 years: stood at $571000.0 in 2021, then sank by 77.41% to $129000.0 in 2022, then surged by 34.11% to $173000.0 in 2023, then retreated by 9.83% to $156000.0 in 2024, then soared by 433.33% to $832000.0 in 2025.
• Business Quant data shows GTHP's Change in Accured Expenses at $832000.0 in Q4 2025, $204000.0 in Q3 2025, and $221000.0 in Q2 2025.